Guided Therapeutics (GTHP) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free GTHP Stock Alerts $0.10 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Guided Therapeutics Short Interest DataCurrent Short Volume26,700 sharesPrevious Short Volume7,500 sharesChange Vs. Previous Month+256.00%Dollar Volume Sold Short$2,563.20Short Interest Ratio / Days to Cover0.9Last Record DateApril 15, 2024Outstanding Shares55,830,000 sharesPercentage of Shares Shorted0.05%Today's Trading Volume2 sharesAverage Trading Volume15,516 sharesToday's Volume Vs. Average0% Short Selling Guided Therapeutics ? Sign up to receive the latest short interest report for Guided Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGTHP Short Interest Over TimeGTHP Days to Cover Over TimeGTHP Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Guided Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202426,700 shares $2,563.20 +256.0%N/A0.9 $0.10 3/31/20247,500 shares $866.25 No ChangeN/A0.2 $0.12 2/29/20246,400 shares $918.40 +392.3%N/A0.1 $0.14 2/15/20241,300 shares $187.33 No ChangeN/A0 $0.14 1/15/20241,300 shares $184.60 No ChangeN/A0.1 $0.14 12/31/20231,300 shares $199.55 -45.8%N/A0 $0.15 Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20232,400 shares $453.60 +242.9%N/A0.1 $0.19 11/30/2023700 shares $94.50 -70.8%N/A0 $0.14 11/15/20232,400 shares $323.40 -64.2%N/A0.1 $0.13 10/31/20236,700 shares $1,005.00 No ChangeN/A0.2 $0.15 9/15/20234,900 shares $686.00 -53.8%N/A0.3 $0.14 8/31/202310,600 shares $1,590.00 -33.8%N/A0.2 $0.15 8/15/202316,000 shares $2,161.60 -0.6%N/A0.6 $0.14 7/31/202316,100 shares $2,334.50 +26.8%N/A0.7 $0.15 7/15/202312,700 shares $2,667.00 +32.3%N/A1.3 $0.21 6/30/20239,600 shares $2,160.00 +47.7%N/A0.2 $0.23 6/15/20236,500 shares $1,040.00 -55.5%N/A0 $0.16 5/31/202314,600 shares $2,774.00 +89.6%N/A1.2 $0.19 5/15/20237,700 shares $1,309.00 -56.7%N/A0.1 $0.17 4/30/202317,800 shares $4,272.00 +17,700.0%N/A0.8 $0.24 4/15/2023100 shares $28.00 -96.9%N/A0 $0.28 3/31/20233,200 shares $736.00 +18.5%N/A0.1 $0.23 3/15/20232,700 shares $796.23 +2,600.0%N/A0.9 $0.29 2/28/2023100 shares $29.00 -95.7%N/A0 $0.29 2/15/20232,300 shares $765.90 +76.9%N/A0.1 $0.33 1/31/20231,300 shares $450.32 No ChangeN/A0.1 $0.35 12/30/20221,200 shares $360.00 -93.9%N/A0 $0.30 12/15/202219,500 shares $6,431.10 -21.4%N/A2.9 $0.33 11/30/202224,800 shares $8,665.12 +13.2%N/A2.5 $0.35 11/15/202221,900 shares $6,132.00 +10.6%N/A1 $0.28 10/31/202219,800 shares $5,940.00 -2.0%N/A0.8 $0.30 10/15/202220,200 shares $9,090.00 -7.8%N/A3.5 $0.45 9/30/202221,900 shares $11,169.00 +10.6%N/A2.3 $0.51 9/15/202219,800 shares $10,543.50 No ChangeN/A2.8 $0.53 8/31/202219,800 shares $9,702.00 -1.5%N/A6.4 $0.49 8/15/202220,100 shares $11,658.00 +133.7%N/A2.4 $0.58 7/31/20228,600 shares $4,472.00 +855.6%N/A1 $0.52 7/15/2022900 shares $512.28 No ChangeN/A0 $0.57 6/15/2022900 shares $427.95 -76.3%N/A0.1 $0.48 5/31/20223,800 shares $1,938.00 +192.3%N/A0.1 $0.51Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide GTHP Short Interest - Frequently Asked Questions What is Guided Therapeutics' current short interest? Short interest is the volume of Guided Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 26,700 shares of GTHP short. Learn More on Guided Therapeutics' current short interest. What is a good short interest ratio for Guided Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GTHP shares currently have a short interest ratio of 1.0. Learn More on Guided Therapeutics's short interest ratio. Is Guided Therapeutics' short interest increasing or decreasing? Guided Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 26,700 shares, an increase of 256.0% from the previous total of 7,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guided Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Guided Therapeutics: Micron Solutions, Inc. (0.07%), Helius Medical Technologies, Inc. (8.52%), ENDRA Life Sciences Inc. (0.07%), Nuwellis, Inc. (12.45%), Tivic Health Systems, Inc. (4.19%), BioSig Technologies, Inc. (10.35%), XWELL, Inc. (1.62%), Calidi Biotherapeutics, Inc. (4.02%), Avenue Therapeutics, Inc. (0.44%), Xenetic Biosciences Inc (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Guided Therapeutics stock? Short selling GTHP is an investing strategy that aims to generate trading profit from Guided Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guided Therapeutics? A short squeeze for Guided Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHP, which in turn drives the price of the stock up even further. How often is Guided Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHP, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Micron Solutions Short Squeeze Helius Medical Technologies Short Squeeze ENDRA Life Sciences Short Squeeze Nuwellis Short Squeeze Tivic Health Systems Short Squeeze BioSig Technologies Short Squeeze XWELL Short Squeeze Calidi Biotherapeutics Short Squeeze Avenue Therapeutics Short Squeeze Xenetic Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GTHP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals